Literature DB >> 8302856

Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.

S H Khan1, S Sorof.   

Abstract

Peroxisome proliferators (PP) are a diverse group of chemicals that induce dramatic increases in peroxisomes in rodent hepatocytes, followed by hypertrophy, hepatomegaly, alterations in lipid metabolism, mitogenesis, and finally hepatocarcinomas. Termed nongenotoxic carcinogens, they do not interact with DNA, are not mutagenic in bacterial assays, and fail to elicit many of the phenotypes associated with classic genotoxic carcinogens. We report here that the mitogenesis induced by the major PP class, the amphipathic carboxylates, and by the tetrazole-substituted acetophenones specifically requires liver fatty acid-binding protein (L-FABP) in cultured rat hepatoma cells transfected with the sense cDNA of L-FABP, in contrast to L-FABP-nonexpressing cells transfected with its antisense cDNA. The mitogenic actions of L-FABP were protein-specific, inasmuch as no other protein in the nonexpressing cells could act like L-FABP. L-FABP was previously shown not only (i) to interact covalently with metabolites of the two genotoxic carcinogens 2-acetylaminofluorene and aminoazo dyes during liver carcinogenesis, but also (ii) to bind noncovalently the two classes of PP in vitro with avidities that correlate with their abilities to elicit peroxisomal enzymatic responses, and (iii) together with unsaturated fatty acids, especially linoleic acid, to promote multiplication of the transfected hepatoma cells in culture. The convergence of the two types of genotoxic carcinogens with the two classes of PP nongenotoxic carcinogens, and also with unsaturated fatty acids, at L-FABP actions in inducing mitogenesis allows the following hypothesis. During tumor promotion of carcinogenesis in vivo, these groups of genotoxic and nongenotoxic carcinogens act on the normal process by which L-FABP, functioning as a specific receptor of unsaturated fatty acids or their metabolites, promotes hepatocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302856      PMCID: PMC521409          DOI: 10.1073/pnas.91.3.848

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Mechanism-based probes of the topology and function of fatty acid hydroxylases.

Authors:  P R Ortiz de Montellano; W K Chan; S F Tuck; R M Kaikaus; N M Bass; J A Peterson
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

2.  Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice.

Authors:  A M Bendele; D M Hoover; R B van Lier; P S Foxworthy; P I Eacho
Journal:  Fundam Appl Toxicol       Date:  1990-11

3.  Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.

Authors:  T Keler; C S Barker; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship.

Authors:  R Sharma; B G Lake; J Foster; G G Gibson
Journal:  Biochem Pharmacol       Date:  1988-04-01       Impact factor: 5.858

Review 5.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

Authors:  J M Hawkins; W E Jones; F W Bonner; G G Gibson
Journal:  Drug Metab Rev       Date:  1987       Impact factor: 4.518

6.  Regulation of mitochondrial and microsomal phospholipid synthesis by liver fatty acid-binding protein.

Authors:  A Vancura; D Haldar
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

7.  Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

Authors:  D S Marsman; R C Cattley; J G Conway; J A Popp
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

8.  Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.

Authors:  M Göttlicher; E Widmark; Q Li; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

9.  Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver.

Authors:  J R Cannon; P I Eacho
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

10.  The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene.

Authors:  J D Tugwood; I Issemann; R G Anderson; K R Bundell; W L McPheat; S Green
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  14 in total

1.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 2.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

3.  Involvement of AP-2 in regulation of the R-FABP gene in the developing chick retina.

Authors:  D A Bisgrove; E A Monckton; R Godbout
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation.

Authors:  Torben Helledie; Claus Jørgensen; Marianne Antonius; Ann M Krogsdam; Irina Kratchmarova; Karsten Kristiansen; Susanne Mandrup
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

Review 5.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

Review 6.  The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.

Authors:  Agata Chmurzyńska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

7.  Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats.

Authors:  GuQi Wang; Qing Ming Chen; Gerald Y Minuk; Yuewen Gong; Frank J Burczynski
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

8.  Transfection of L6 myoblasts with adipocyte fatty acid-binding protein cDNA does not affect fatty acid uptake but disturbs lipid metabolism and fusion.

Authors:  C F Prinsen; J H Veerkamp
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

Review 9.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

10.  Brain fatty acid binding protein (Fabp7) is diurnally regulated in astrocytes and hippocampal granule cell precursors in adult rodent brain.

Authors:  Jason R Gerstner; Quentin Z Bremer; William M Vander Heyden; Timothy M Lavaute; Jerry C Yin; Charles F Landry
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.